VANCOUVER, BC / ACCESSWIRE / December 11, 2023 / WEX Pharmaceuticals Inc. "WEX" or the "Company", a biotechnology company developing Halneuron® Tetrodotoxin or TTX for pain, announced that it has commenced its Quantitative Sensory Testing QST clinical trial and is actively recruiting participants into this clinical trial. The QST clinical trial is being conducted in the... Lire le communiqué |